Wheat is a staple food for more than one-third of the world’s population, and improving its yield and quality is essential for global food security. On April 1, the State Key Laboratory of Genome and Multi-omics Technologies, initiated by BGI-Research, together with scientists from 34 universitie...
Learn details
On March 27, 2026, the leading global forensic scientist, and outstanding mentor and friend of BGI, Dr. Henry Lee, passed away peacefully in the United States at the age of 87. In remembrance of Dr. Henry Lee (1938–2026) (Credit: University of New Haven). Dr. Lee’s life was dedicate...
Learn details
The human gut harbors vast numbers of bacteriophages that help shape microbial communities, yet for most of these phages the bacterial host remains unknown. In the Gut Phage Database (GPD), hosts had been assigned to fewer than 29% of 142,809 cataloged phage genomes, leaving much of the gut virom...
Learn details
The International Organization for Standardization (ISO) has officially released the first international standard for therapeutic bacteriophage preparation, titled “ISO/TS 20853:2026 Biotechnology — Bioprocessing — General requirements for bacteriophage preparation for therapeutic use.” This grou...
BGI Group, in collaboration with leading academic and research institutions such as China Jiliang University, China National Institute of Metrology, and the National Institutes for Food and Drug Control, has successfully spearheaded the development of GB/T 47145-2026: “Recombinant protein reagent...
On February 18, 2026, researchers from BGI-Research's State Key Laboratory of Genome and Multi-omics Technologies, working with collaborators at The Chinese University of Hong Kong, Shenzhen, reported in Chemical Science a quantum–classical hybrid approach for modeling electron transfer in a...
Hemogen Therapeutic, a gene therapy company and subsidiary of BGI Group, in collaboration with Shenzhen Children’s Hospital, has published clinical research in the international, peer‑reviewed journal Molecular Therapy on hemobeglogene autotemcel (hemo-cel), an investigational gene therapy for tr...
On February 23, 2026, a research team from the State Key Laboratory of Genome and Multi-omics Technologies at BGI-Research reports in Nature Communications an end-to-end nanopore sensing workflow designed to profile peptides and support protein identification at high throughput. By combining a st...
Cell-free DNA (cfDNA) is made of tiny DNA fragments released into the bloodstream when cells break down. Because these fragments carry valuable biological signals, cfDNA has become a cornerstone of modern “liquid biopsy” approaches, including non-invasive prenatal testing (NIPT) and emerging tool...